New poly(L-lysine)-b-poly(ethylene glycol) copolypeptides have been prepared, where the side-chain amine groups of lysine residues are modified to contain ortho-amine substituted phenylboronic acid, i.e. Wulff-type phenylboronic acid (WBA), groups to improve their pH responsive, carbohydrate binding properties. These block copolymers form nanoscale complexes with glycosylated proteins that are stable at physiological pH, yet dissociate and release the glycoproteins under acidic conditions, similar to those found in endosomal and lysosomal compartments within cells. These results suggest that WBA modified polypeptide copolymers are promising for further development as degradable carriers for intracellular protein delivery.
Introduction
Many biological therapeutics, such as for enzyme-based therapies, require a carrier to reduce their clearance by the immune system as well as for delivery into cells or cellular compartments where they are needed [1] . Stimulus responsive carriers, such as those that respond to pH or redox, are especially desirable as they can be a means to effect release of therapeutic cargos upon cellular uptake [2] . For these reasons, the reversible and pH responsive diol-binding characteristics of phenylboronic acid (PBA) groups have been used in many carriers proposed for delivery of glycosylated therapeutics [3] . Recent efforts in this area have focused on PBA groups that have been modified with tethered OH and NR 2 groups [4] , which adjust the properties of diol-PBA complexes so that they have increased stability at neutral pH, and can yet release their cargos at more acidic pH as found in endosomal and/or lysosomal compartments.
Although some PBA-containing polypeptides have been reported for development as therapeutic carriers, these have primarily utilized simple PBA groups, which form only weak complexes with carbohydrate diol groups at physiological pH [5] . Here, we have prepared new poly(L-lysine)-b-poly(ethylene glycol), K 8 PEG 44 , copolypeptides, where the side-chain amine groups of lysine residues have been modified to contain ortho-substituted amine PBA, i.e. Wulff-type phenylboronic acid (WBA) [6] , groups (K WBA 8 PEG 44 , 1, Equation 1) to improve their pH responsive diol binding properties [4a,7] . These block copolymers were found to form nanoscale complexes with glycosylated proteins that were stable at physiological pH, yet were found to dissociate and release the glycoproteins at acidic conditions (pH 5.0), similar to those found in endosomal and lysosomal compartments.
-4 -Previously, polypeptides modified with PBA groups have been prepared mainly via amide linkages between para-and meta-substituted PBAs and the side-chain functional groups of lysine, glutamic acid, and aspartic acid [5] . These functional polypeptides, pioneered by Shinkai [5a,b], were studied for their carbohydrate binding abilities and nanoparticle formation upon complexation with diol-containing, as well as thermoresponsive or oppositely charged, polymers. A drawback of these systems is the low stability of the PBAdiol complexes at physiological pH, due to the high pK a of PBA groups, which prohibits stable complex formation using PBA-diol binding alone [7] . It has been shown that substitution of the phenyl ring of PBAs can be used to reduce the pK a of these groups [7] , which increases the stability of the their diol-complexes at physiological pH, and allows for complex dissociation at pH 5 to 6 that is desirable for endosomal or lysosomal release within cells.
Examples of such polymer side-chain modifications include meta-nitro-PBAs [8] , benzoboroxoles [4b-d] , and WBAs (ortho-amino-PBAs) [4a,7] , which have been studied in a number of carrier designs. A potential limitation of some of these systems is their use of fully Jordi Labs 5 μm mixed bed column with 0.5 wt% potassium trifluoroacetate in HFiP as the eluent at 60 °C. All GPC/LS samples were prepared at concentrations of 10 mg/mL.
Experimental Procedures
Poly(L-lysine hydrochloride) 8 -b-poly(ethylene glycol) 44 , K 8 PEG 44 . This copolymer was prepared by a procedure similar to methods previously reported [9] . In a N 2 filled glove box, Cbz-Lys NCA (570 mg, 1.9 mmol) was dissolved in anhydrous DMF (50 mg/mL). To the stirred solution was added (PMe 3 ) 4 Co (67 µL of a 50 mg/mL solution in 1:1 DMF/THF) via syringe. After 2 h an aliquot (20 µL) was removed for analysis by FTIR, which confirmed that all of the NCA had been consumed. To the reaction mixture was then added PEG 44 -NCO (480 mg, 2.6 eq. per Co). The mixture was stirred for an additional 16 h and then removed from the glove box. The majority of the solvent was removed under reduced pressure, and the polymer was then precipitated by addition of water (15 mL) to the concentrated solution (ca. 4 mL)
followed by additional washing with water (3 x 15 mL), then was lyophilized to dryness. The crude polymer product (ca. 1.9 mmol lysine residues) was dissolved in TFA (25 mL), and the mixture cooled in an ice bath. To this solution was added 33% HBr/AcOH (1.7 mL, 9.2 mmol) and the reaction was stirred for 5 h, followed by solvent removal using rotary Figure S1 ).
-7 -Poly(Nε-(2-boronobenzyl)-L-lysine) 8 
Results and Discussion
In initial studies, we attempted to prepare conjugates of either meta-nitro-PBAs or WBAs to the side-chain amine groups in poly(L-lysine). At high degrees of functionalization, the metanitro-PBA modified poly(L-lysine) samples possessed minimal water solubility, and the WBA modified poly(L-lysine) samples only possessed reasonable water solubility at short chain lengths. Based on these results, we designed and prepared block copolymer 1, which contains a 2 kDa PEG segment attached to a short, WBA functionalized, oligo(L-lysine) segment (Equation 1). The PEG segments were used as biocompatible, non-interacting, water -10 -solubilizing chains to limit aggregation of WBA-diol complexes [2] . To prepare the WBA conjugates, ortho-formyl-PBA was attached to lysine side-chains via reductive amination [5c,7c,14] , which directly introduced the ancillary ortho-aminomethyl functionality, characteristic of WBAs, into the PBA groups. Previous studies have shown that the secondary aminomethyl-WBA groups, as used here, behave similarly to tertiary aminomethyl-WBA groups that are also of interest [7] . The resulting WBA-containing copolymer 1 was found to be water soluble over a range in pH from 3.0 to 9.0, and was thus suitable for diol-binding studies. We also prepared the para-amide linked PBA analog of 1, (K PBA 8 PEG 44 , 2, see SI, Scheme S1) for use as a control polymer in complexation experiments.
To verify that copolymer 1 is capable of binding specifically to diol groups, we performed initial complexation studies using Alizarin Red S (ARS). Since its optical properties change upon complexation of its catechol group to aryl boronic acids, ARS has been used to detect binding of PBAs to diols via UV/Vis or fluorescence spectroscopy [12] .
When 1 was added to ARS in aqueous solution, a color change from red to yellow-orange was observed. Fluorimetry was used to further probe the specificity of the interaction between ARS and 1 (Figure 1) . To an aqueous solution of ARS (0.1 mM) and 1 (1.0 mM) at pH 7.4 was added increasing amounts of catechol (0 to 100 mM, see SI, Figure S2) , which was used to compete with ARS for complexation with 1. The fluorescence of the ARS-1 complex decreased with increasing catechol concentration, as would be expected for conversion of ARS-1 into catechol-1 complexes in the presence of excess catechol (Figure 1, Figure S2 ).
These studies confirmed that copolymer 1 was capable of reversibly binding diol-containing molecules.
To evaluate the ability of copolymer 1 to form complexes with a glycosylated protein, our initial studies utilized horseradish peroxidase (HRP), a readily available, glycosylated enzyme with a total carbohydrate content of 18 to 22% [15] . Complex formation between HRP and 1 was studied by dynamic light scattering (DLS) analysis of mixtures of 1 and HRP -11 -(ca. 10 boronic acid groups per monosaccharide) in aqueous buffers ranging from pH 7.4 to pH 5.0 (Figure 2) . DLS analysis showed that 1 and HRP, separately in solution, did not show any aggregation behavior in the range of pH studied. When solutions of 1 and HRP were mixed, their aggregation into multimeric complexes of ca. 25 to 65 nm average diameter was found to occur at both pH 7.4 and pH 6.5. At pH 5.0, no aggregation was seen in mixtures of 1 and HRP, showing that complexation between 1 and HRP is pH-dependent and that no complexation occurs at this pH (Figure 2) . The exact ratio of 1 to HRP in the complexes was not be determined due to the unknown and variable degree and type of glycosylation in this protein [15] .
The complexes between 1 and HRP at pH 6.5 and 7.4 were stable over time in buffer (48 hours, 22 ºC), and possessed average diameters that would be desirable for bloodstream circulation and passive targeting via the enhanced permeation and retention (EPR) effect [16] .
To determine if the HRP complexed with 1 remained in active form, an assay using the chromogenic HRP substrate 2-2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) was conducted and showed that complexed HRP did not lose activity relative to free HRP (see SI, Figure S3 ) [13] . As an additional control to confirm that aggregation of 1 with HRP involved glycosylation sites on HRP, we also studied the ability of copolymer 1 to form complexes with a non-glycosylated protein, bovine serum albumin (BSA). At pH 7.4, no complex aggregates were observed by DLS to form between 1 and BSA (Figure 3a) , which suggests that the presence of surface carbohydrates on a protein are necessary for strong complexation with 1 under these conditions. Further, we also observed that addition of catechol to complexes of 1 and HRP resulted in dissociation of the complexes, due to the preferential binding of catechol to WBA groups in 1 (see SI, Figure S4 ) [12] . To confirm that pH responsive complexation of HRP with 1 is due to its WBA groups, we also studied the ability of PBA containing copolymer 2 to form complexes with HRP. Copolymer 2 was found by DLS analysis to be unable to form complex aggregates with HRP even at pH -12 -7.4, which is likely due to the high pK a of the PBA groups (Figure 3b) [7]. These control experiments show that complexes of 1 and HRP do not denature the enzyme, are likely due to complex formation between WBA and surface carbohydrate groups, and that the structure of the WBA group greatly enhances complex stability at physiological pH, and allows for HRP release at pH 5.0.
To show the results obtained above for 1 and HRP are not specific to that protein, and also show an example with therapeutic potential, we studied the ability of copolymer 1 to form complexes with alpha-L-iduronidase (IDUA), a glycosylated enzyme used for enzyme replacement therapy for the treatment of mucopolysaccharidosis I [17] . Complex formation between IDUA and 1 was studied using DLS analysis of mixtures of 1 and IDUA (ca. 10 boronic acid groups per monosaccharide) in aqueous buffers ranging from pH 7.4 to pH 5.0 (Figure 4) . Similar to results seen with HRP, DLS analysis showed that 1 and IDUA, separately in solution, did not show any aggregation behavior in the range of pH studied.
When solutions of 1 and IDUA were mixed, their aggregation into complexes of ca. 50 to 125 nm average diameter was found to occur at both pH 7.4 and pH 6.5. At pH 5.0, no aggregation was seen in mixtures of 1 and IDUA, showing that complexation between 1 and IDUA is pH-dependent and that no complexation occurs at this pH (Figure 4) . These results are similar to those obtained using HRP, and suggest that copolymer 1 has potential for pH dependent complex assembly with a variety of different glycosylated proteins.
Conclusions
We have described the synthesis of a new WBA functionalized polypeptide-PEG copolymer, 
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